Elevated ambient glucose induces acute inflammatory events in the microvasculature: effects of insulin.
We employed intravital microscopy of the rat mesenteric microvasculature to study the effects of local hyperglycemia on leukocyte-endothelial cell interactions. Intraperitoneal injection of 6, 12.5, and 25 mmol/l D-glucose to the rat significantly and time-dependently increased leukocyte rolling and leukocyte adherence in, and leukocyte transmigration through mesenteric venules compared with control rats injected with Krebs-Henseleit (K-H) solution alone or given 25 mmol/l L-glucose intraperitoneally. The response elicited by D-glucose was associated with significant attenuation of endothelial nitric oxide (NO) release, as demonstrated by direct measurement of NO release in inferior vena caval segments isolated from rats exposed to 25 mmol/l D-glucose for 4 h (P < 0.01 vs. vena caval segments from control rats). Local application of 0.05 U/min insulin for 90 min significantly attenuated glucose-induced leukocyte rolling, adherence, and migration (P < 0.01 from 25 mmol/l D-glucose alone). Immunohistochemical localization of P-selectin expressed on endothelial surface was significantly increased 4 h after exposure of the mesenteric tissue to high ambient glucose (P < 0.01 vs. ileal venules from rats injected with K-H solution alone or 25 mmol/l L-glucose). Insulin markedly inhibited endothelial cell surface expression of P-selectin in ileal venules exposed to elevated ambient glucose in vivo (P < 0.01 vs. control rats injected with 25 mmol/l L-glucose). These data demonstrate that acute increases in ambient glucose comparable to those seen in diabetic patients are able to initiate an inflammatory response within the microcirculation. This inflammatory response to glucose is associated with upregulation of the endothelial cell adhesion molecule P-selectin and can be blocked by local application of insulin.
Booth
G
G
Department of Physiology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA.
Stalker
T J
TJ
Lefer
A M
AM
Scalia
R
R
D000208:Acute Disease; D000818:Animals; D001202:Ascitic Fluid / Q000378:metabolism; D001786:Blood Glucose / Q000378:metabolism*; D002450:Cell Communication / Q000276:immunology; D003921:Diabetes Mellitus, Experimental / Q000276:immunology / Q000378:metabolism; D003925:Diabetic Angiopathies / Q000276:immunology / Q000378:metabolism; D004730:Endothelium, Vascular / Q000737:chemistry / Q000166:cytology / Q000276:immunology; D005947:Glucose / Q000494:pharmacology; D006943:Hyperglycemia / Q000276:immunology / Q000378:metabolism; D007004:Hypoglycemic Agents / Q000097:blood / Q000494:pharmacology*; D007150:Immunohistochemistry; D007328:Insulin / Q000097:blood / Q000494:pharmacology*; D007962:Leukocytes / Q000166:cytology / Q000276:immunology; D008297:Male; D008833:Microcirculation / Q000187:drug effects / Q000276:immunology; D008853:Microscopy / Q000379:methods; D009569:Nitric Oxide / Q000378:metabolism; D019007:P-Selectin / Q000032:analysis / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D013152:Splanchnic Circulation / Q000187:drug effects / Q000276:immunology*; D014657:Vasculitis / Q000276:immunology / Q000378:metabolism*; D014682:Vena Cava, Inferior / Q000187:drug effects / Q000378:metabolism
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin; D019007:P-Selectin; D009569:Nitric Oxide; D005947:Glucose